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 Abstract 
BACKGROUND: Studies in vitro and in vivo demonstrate that membrane/lipid rafts (MLR) and caveolin 
(Cav) organize pro-growth receptors, and when over-expressed specifically in neurons, Cav-1 augments 
neuronal signaling and growth, and improves cognitive function in adult and aged mice. However, 
whether Cav-1 overexpression can preserve motor and cognitive function in the setting of brain trauma is 
unknown. 
METHODS: Here, we engineered a neuron-targeted Cav-1 overexpressing transgenic (Tg) mouse (via 
synapsin promoter, SynCav1 Tg) and subjected it to a controlled cortical impact (CCI) model of brain 
trauma and measured biochemical, anatomical, and behavioral changes. 
RESULTS: SynCav1 Tg mice exhibited increased hippocampal expression of Cav-1 and 
MLR-localization of PSD-95, NMDAR, and TrkB.  When subjected to CCI, SynCav1 Tg mice 
demonstrated preserved hippocampal-dependent fear learning and memory, motor function recovery on 
inverted grid, and decreased brain lesion volume.  
CONCLUSIONS: Neuron-targeted overexpression of Cav-1 in the adult brain preserves 
hippocampal-dependent learning and memory, restores motor function after brain trauma, and decreases 
brain lesion size. Our findings suggest neuron-targeted Cav-1 as a novel therapeutic strategy to restore 
nerve function and prevent trauma-associated neurodegeneration.  
 
Introduction 
 Brain injury is a debilitating event that occurs when individuals are exposed to an external force that 
induces a focal and/or diffuse mechanical neuronal injury (axons and dendrites) and a damaged, 
growth-inhibitory environment resulting in chronic neurodegeneration. Individuals afflicted with various 
forms of nerve injury exhibit impaired motor and cognitive function, sensory loss, and chronic pain 
accompanied with poor functional recovery(1-4). The resultant nerve injury within the brain is a major 
contributing risk factor to neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease (AD 
and PD), and amyotrophic lateral sclerosis (ALS)(1-6).  
Nerve injury involves a biphasic progression(3, 7-9) consisting of an initial primary mechanical insult 
to neurons, followed by a secondary, delayed injury due to micro- and astrogliosis, and production of 
glial-derived myelin-associated growth inhibitors that limit neuroregenerative potential(10, 11). On a 
subcellular level, nerve injury decreases expression and subcellular localization of neuronal growth 
promoting receptors(12) and blunts production of downstream mediators of neuroplasticity(13, 14). This 
hostile environment limits the brain’s regenerative capacity and ultimately leads to neurodegenerative 
disorders. 
Genetic interventions that evoke intrinsic neuro-regenerative signaling cascades have the potential 
to restore functional network connectivity and improve functional recovery after nerve injury. Neuronal 
growth signaling pathways are dependent upon establishing a polarized plasma membrane and the 
localization of growth-promoting receptors to these polarized platforms(15). These platforms are 
composed of membrane lipid rafts (MLR), plasmalemmal microdomains enriched in sphingolipids, 
cholesterol, and scaffolding proteins known as caveolins (Cavs)(15). Within MLR, Cav-1 
compartmentalizes key growth-promoting receptors in order to enhance ‘high-fidelity’ signal 
transduction(15-18). However, following nerve injury, the subcellular localization of these signaling 
components are significantly disorganized and/or decreased(12-14), which in part may explain for the 
inability of injury neurons to re-establish functional connections weeks to months after trauma.  
 We have previously shown that neuron-targeted overexpression of Cav-1 (achieved by linking it to a 
neuron-specific synapsin promoter [SynCav1]) enhances MLR formation, augments receptor-mediated 
cAMP production, TrkB signaling, and dendritic growth and arborization even in the presence of 
myelin-associated growth inhibitors(17). Moreover, SynCav1 delivery to the hippocampus in vivo 
increased MLR and MLR-localized expression of TrkB, promoted structural and functional hippocampal 
neuroplasticity, and improved hippocampal-dependent learning and memory in aged mice(18), 
suggesting that genetic interventions that target MLR and Cav-1-associated microdomains may enhance 
the efficacy of existing pharmacologic agents or already present endogenous growth factors to improve 
neuronal function after nerve injury or in the neurodegenerative brain. 
 The present study tested whether neuron-targeted over-expression of Cav-1 can protect neurons 
against brain trauma and improve behavioral recovery. To achieve this, we engineered a SynCav1 
transgenic mouse (SynCav1 Tg) and subjected it to a controlled cortical impact (CCI) model of brain 
trauma model(12).  Akin to our results with the SynCav1 gene construct in vitro and in vivo(17, 18), 
biochemical characterization of SynCav1 Tg mice demonstrated higher Cav-1 expression and increased 
MLR-localization of synaptic components (e.g., PSD95, NMDAR and TrkB).  Two months following CCI, 
SynCav1 Tg mice exhibited preserved hippocampal-dependent fear learning and memory, better motor 
function recovery, and smaller brain lesion when compared to Tg negative (Tg neg). These results are the 
first to demonstrate that global neuron-targeted overexpression of Cav-1 preserves and/or restores 
cognitive and motor function after brain trauma, and extend previous work from our group that 
neuron-targeted Cav-1 may be exploited as a potential therapeutic target for promoting functional 
neurooplasticity after trauma or in certain neurodegenerative conditions such as AD, PD, and ALS.    
 
METHODS and MATERIALS 
Animals  
All mice (C57BL/6; Jackson Laboratories) were treated in compliance with the Guide for the Care and Use 
of Laboratory Animals (National Academy of Science, Washington, D.C.). All animal use protocols were 
approved by the Veterans Administration San Diego Healthcare System Institutional Animal Care and 
Use Committee (IACUC, San Diego, California) prior to procedures performed. Male adult (4 month) mice 
were housed under normal conditions with ad libitum access to food and water. Two weeks after behavior 
testing all mice were euthanized with 50 mg/kg pentobarbital and brain tissue was processed for histology 
and measurement of lesion size as previously described(12). SynCav1 transgenic (SynCav1 Tg) mice 
were generated in C57BL/6 background through the UCSD mouse transgenic core(19).  Full length 
Cav-1 cDNA (537 bp) was cloned into a vector containing the human neuron-specific synapsin promoter 
(495 bp)(20) and termed SynCav1 as previously described(17, 18).  SynCav1 DNA construct (free of 
ethidium bromide) was used for microinjection (UCSD Transgenic Core).  Transgene negative (Tg neg) 
and SynCav1 transgene positive (SynCav1 Tg) mice were used for this study. Mice were allocated to 4 
groups: Sham Tg neg, TBI Tg neg, Sham SynCav1 Tg, and TBI SynCav1 Tg. 
 Genotyping  
SynCav1 transgene (SynCav1) positive mice were confirmed by tail DNA extraction and polymerase 
chain reaction (PCR). Briefly, genomic DNA was extracted from tail tissue samples using the Qiagen 
DNeasy Blood and Tissue Kit (# 69504). PCR was performed for SynCav1 genes using the following 
protocol: denaturation at 95°C for 5 minutes, followed by 30 cycles at 95°C for 30 seconds, 58.5°C for 30 
seconds, and 72°C for 45 seconds, and then 72°C for 7 minutes and hold at 4°C. All of the primers are 
purchased from Integrated DNA Technologies and shipped in lyophilized form. The oligonucleotide primer 
sequences are as follows: SynCav1 Forward [5'-CAG CTT CAG CAC CGC GGA CA-3’ (#138389038)] 
and SynCav1 Reverse [CAC CTC GTC TGC CAT GGC CT-3’ (#138389039)] were used to detect a 
product size of 470 bp (Figure 1A lower bands). For genotyping control, vinculin Forward [Ex3 823F: 
5'-CCT GCG CGG GAT TAC CTC ATT GAC-3' (#138389036)] and vinculin Reverse [Ex4 1642R: 5'-TGC 
TCA CCT GGC CCA AGA TTC TTT-3' (#138389037)] were used to detect a product size of 860 bp. PCR 
products were separated on a 1 % agarose gel and run for 35 minutes at 135 volts. 
 
Biochemical Characterization of Membrane/Lipid Rafts (MLR)   
Sucrose density fraction of mouse brains were performed as previously described(12, 17, 18). Mice were 
sacrificed by rapid decapitation under isoflurane (5%) anesthesia. The whole brain was quickly removed 
and hippocampal tissue (bilateral, CA regions and dentate gyrus combined, 50-100 mg) was dissected 
and homogenized using a carbonate lysis buffer (500 mM sodium carbonate, pH 11.0) containing 
protease and phosphatase inhibitors. Protein was quantified by Bradford assay and normalized to 0.5 
mg/ml. Sucrose density gradients were prepared as previously reported. Membranes samples (f4-5 and 
f10-12) were incubated overnight with primary antibodies for Cav-1 (Cell Signaling #3238, 1:1000), 
β3-tubulin (Abcam ab18207, 1:1000), TrkB (BD Biosciences 610102, 1:1000), or NMDAR2A (abcam 
ab124913, 1:750), NMDAR2B (abcam ab28373, 1:750), or PSD95 and probed with species-specific 
secondary antibodies conjugated to HRP. Densitometric analysis (arbitrary units) was conducted as 
previously described(12, 17, 18). 
 Controlled Cortical Impact (CCI) Model  
Mice were fixed into a stereotactic frame under isoflurane anesthesia (5% induction for 30 sec followed by 
1.5% maintenance mixed with oxygen at 1 liter/min). A portable drill was used to perform a craniotomy 
over the right hemisphere to generate a burr hole exposing a portion of the primary and secondary motor 
cortex and parietal-temporal cortex (+1 to − 4 A-P from the bregmatic suture and 4 mm laterally from the 
sagittal suture), a modification of our previously publishes work with the CCI model(12). The bone flap 
was carefully removed and a 3 mm diameter piston was centered on dura at approximately +0.5 to -2.5 
mm bregma and 3 mm lateral to the saggital suture. Using a stereotaxic impactor (Impact OneTM; 
myNeuroLab.com), the 3 mm diameter piston was accelerated at a speed of 5 m/second; the depth of the 
impact was 1 mm below the cortical surface. Animals were placed on a 37°C warm water blanket to until 
they awoke post-surgery. 
 
Histology and Lesion Volume Analysis  
To measure the lesion volume, animals were transcardially perfused with 4% paraformaldehyde in 0.1 M 
PO4 buffer 2 months post-CCI. After perfusion, samples were stored in the same buffer for 24 hours and 
processed for histology. Serial coronal hippocampal sections (100 µm serial sections) were stained with 
Cresyl Violet (Abcam). Sections were mounted on superfrost slides, dried overnight and processed for 
citric acid treatment(21). After cooling with 1xPBS sections were incubated with Cresyl Violet for 15 
minutes at RT and washed with 1xPBS 3x. Following washes sections were dehydrated with ethanol and 
cleared with citrasolv and coverslipped with DPX (electron microscopy sciences). To image the entire 
coronal sections from +4.2 to -5.6 bregma, 15-25 pictures were obtained at 10X on a BZ9000 Imager 
(Keyence Osaka, Japan) and were combined using the image stitching function of the BZ-X Analyzer 
software. For quantitation of lesion volume, digital virtual slides obtained with Aperio Scanscope CS-1 
scanner were used for extensive computer assisted morphometry in a Spectrum image analysis system 
(Aperio Technology Inc., 1700 Leider Lane, Buffalo Grove, IL, 60089, USA) followed by Scanscope 
software and associated algorithm analysis as previously described(12, 22). 
 Inverted Grid Test   
We performed the inverted grid at baseline, and weekly intervals starting at day 7 up to day 49 post 
impact to measure basic motor function in our animals. The inverted grid test measures the mouse’s 
ability to voluntarily hang on an inverted wire mesh(23). The apparatus is elevated 40 cm above the 
ground with a soft surface underneath to prevent physical trauma to the mice. Latency to fall 
measurements were repeated 3-times with an inter-trial interval of 30 seconds (sec). The holding impulse 
was then calculated by multiplying the longest hanging duration of the three trials by the mouse’s body 
weight [time (sec.) * body weight (g)]. 
 
Fear Conditioning Behavior   
Fear conditioning was performed as previously described(18). Foot shocks were delivered through the 
floor consisting of 36 stainless steel rods wired to a shock generator. Presentation of unconditioned 
stimuli (US: scrambled foot shock) and conditioned stimuli (CS: auditory tone) were controlled by 
computer (Med Associates Inc.). Freezing was determined using analysis software (Video Freeze®, Med 
Associates Inc., ANY-MAZE, San Diego Instruments).  Training: After an acclimation period (2 min), 
mice were presented with a tone (CS: 90 dB, 5 kHz) for 30s that co-terminated with a foot shock (US: 2.0s, 
1.0 mA) in dark chambers. A total of three tone-shock pairings were presented with a varying inter-trial 
interval of 30-90s. Freezing was measured during each CS to measure fear acquisition level across 
groups. Context fear was tested twenty-four hours later. Cued fear was tested twenty-four hours after 
context fear. To remove contextual cues, the chambers were altered across several dimensions (odor - 
scent; visual – light chambers and walls are altered via plastic inserts; tactile – smooth plastic floor 
covering) to minimize generalization from the conditioning context. The session started with a 3 min 
acclimation period, during which time no tones were presented (“pre-tone” period), then 10 blocks of 5 
CSs were presented for 30s each with an inter-trial interval of 5s. Freezing was recorded during each CS 
presentation. For analysis, total freezing was averaged as total freezing during all CS presentations.  
 
Statistical Analyses   
Data were checked for normal distribution and then analyzed with 2-way repeated measure ANOVA, 
2-way ANOVA, or student’s t-test. Following, unpaired t-tests and Fisher’s LSD post hoc comparison were 
performed as appropriate. For the analysis we used IBM SPSS v22 and GraphPad Prism 6 (La Jolla, CA). 
Data are presented as mean ± SEM. Significance was assumed when p < 0.05. Experimental groups 
were blinded to the experimenters and code was broken only for analysis as previously described(18). 
 
RESULTS 
Synapsin-Caveolin-1 Transgenic (SynCav1 TG) Mice have more MLR and MLR-Associated 
Synaptic Receptors  
SynCav1 TG positive mice were confirmed by polymerase chain reaction (PCR) and ethidium bromide 
DNA gel electrophoresis (Figure 1). SynCav1 appears at 470 bp as indicated by the white arrow on left 
side of DNA molecular ladder. Vinculin (upper band) was used as a loading control (860 bp). To assess 
whether SynCav1 Tg positive mice exhibited changes in MLR-associated proteins, sucrose density 
fractionation was performed on hippocampal (Hpc) homogenates from negative and positive TG mice 
followed by immunoblot blot assay and analysis. Hpc homogenates from SynCav1 TG positive mice 
showed a significant (n = 3-4 mice/group; TG negative vs. SynCav1 TG positive, respectively) increase in 
Cav-1 [0.39 ± 0.03 vs 0.79 ± 0.02; (t(6) = 10.55, p < 0.001)], PSD95 [0.55 ± 0.03 vs 0.88 ± 0.04; (t(6) = 
6.27, p < 0.001)], NMDAR2A (NR2A) [0.78 ± 0.02 vs 2.18 ± 0.32; (t(5) = 3.77, p = 0.01)], NR2B [0.52 ± 
0.04 vs 1.50 vs 0.09; (t(4) = 9.99, p = 0.0006)], and TrkB [0.73 ± 0.22 vs 1.94 ± 0.16; (t(5) = 4.55, p = 
0.006)] protein expression compared to Hpc from TG negative mice (Figure 2A & 2B). Sucrose density 
fractionation revealed a significant increase in Cav-1 [11061 ± 1740 vs 20517 ± 2550; (t(4) = 3.06, p = 
0.04)], PSD95 [8423 ± 907 vs 24587 vs 2408; (t(4) = 6.28, p = 0.003)], NR2A [9859 ± 511 vs 13951 ± 212; 
(t(4) = 7.39, p = 0.002)], NR2B [9308 ± 900 vs 17685 ± 2200; (t(4) = 3.52, p = 0.02)], and TrkB [12944 ± 
1064 vs 18183 ± 1659; (t(6) = 2.66, p = 0.04)] in buoyant fractions 4 and 5 (MLR fractions) indicating an 
increased in MLR-associated synaptic proteins (Figure 2B & 2C).  
 
SynCav1 TG Mice Exhibit Improved Motor Function Recovery after Brain Trauma   
We have previously shown that TBI decreases MLR and MLR-associated synaptic protein complexes(12), 
all of which are important for neuroprotection(16), neuronal signaling and plasticity(17), and 
neurobehavior(18).  As evident in Figure 2, because SynCav1 Tg mice expressed more MLR and 
MLR-localized synaptic proteins necessary for neuroprotective signaling, we therefore tested whether 
these mice exhibited a neuroprotective phenotype following TBI. To analyze motor function using the 
Inverted Grid, we performed a 2-way Repeated Measure ANOVA with ‘gene’ and ‘TBI’ as the between 
subject factor (n = 11 – 22 mice/group). The Inverted Grid test revealed a significant effect of time 
(Greenhouse-Geisser correction: F (2.4,164.5) = 10.61, p < 0.001) and time * TBI (Greenhouse-Geisser 
correction: F (2.4,164.5) = 5.58, p = 0.003) for the recovery period between 7 and 49 days post injury, 
while the time * strain (Greenhouse-Geisser correction: F (2.4,164.5) = 0.81, p = 0.47) or time * TBI * 
strain interaction (Greenhouse-Geisser correction: F (2.4,164.5) = 1.02, p = 0.37) was not significantly 
different between groups. No significant baseline difference before injury between groups was observed. 
We then assessed recovery from injury over time by comparing, within each group, the change from the 
first (day 7) to the last (day 49) day post TBI or sham surgery. Interestingly all groups, except for the Tg 
neg subjected to TBI, significantly increased their holding impulse over this time period as assessed by a 
paired t-test (Figure 3). Specifically, the Holding Impulse [body weight (g) * hanging time (sec.)/102] was 
increased between day 7 and day 49 for sham-Tg neg [34.1 ± 6.1 vs 67.0 ± 13.8; (t(20) = -3.28, p = 
0.004)], sham-SynCav1 [37.0 ± 7.4 vs 87.1 ± 17.6; (t(10) = -3.51, p = 0.006)], and TBI-SynCav1 [20.4 ± 
3.1 vs 33.0 ± 5.1; (t(21) = -3.00, p = 0.007)], respectively. This was not the case for TBI-Tg neg mice [17.0 
± 3.0 vs 21.7 ± 3.4; (t(19) = -1.86, p = 0.08)].  These results demonstrate that 7 weeks after being 
subjected to TBI, SynCav1 TG positive, but not Tg negative mice, exhibited motor function recovery. 
 
SynCav1 TG Mice Show Preserved Contextual Fear Memory and Smaller Lesion Size after Brain 
Trauma   
We have previously shown that SynCav1 gene delivery to the brain improves hippocampal-dependent 
learning and memory in adult and aged mice(18).  Therefore, in the present model we wanted to assess 
hippocampal function in our SynCav1 transgenic mouse after TBI (Figure 4). A 2-way Repeated Measure 
ANOVA with ‘gene’ and ‘TBI’ as the between subject factor was performed for percent freezing during the 
learning phase on day 1. Fear conditioning revealed no learning difference between groups (n = 21-22 
mice/group) during the acquisition period, represented by no significant effect of ‘time * gene * TBI’ 
(Huynh-Feldt correction: F (1.67,145.66) = 0.18, p = 0.80) (Figure 4A). In all groups, similar increases in 
freezing over time with repeated CS-US pairing trials were apparent (Huynh-Feldt correction: F 
(1.67,145.66) = 196.26, p < 0.001). On day 2, contextual re-exposure was performed to assess 
hippocampal-dependent learning and memory. The 2-Way ANOVA revealed a trending (p < 0.1) 
interaction for ‘TBI * strain’ F (1,82) = 3.066, p = 0.08) with decreased % freezing in Tg neg mice 
subjected to TBI (Figure 3b, black bars), with no significant main factor effect for ‘TBI’ F (1,82) = 1.81, p = 
0.18) or ‘strain’ F (1,82) = 1.96, p = 0.17).  In contrast, SynCav1 Tg mice subjected to TBI TBI exhibited a 
similar % freezing to that observed in Tg neg sham mice [post hoc Fisher’s LSD comparison between Tg 
neg/Sham (40.0 ± 3.65 % Freezing) and Tg neg/TBI (29.72 ± 2.03) (t(82) = 2.17, p = 0.03), as well as Tg 
neg/TBI (29.72 ± 2.03) and SynCav1/TBI (40.19 ± 2.69) (t(82) = 2.23, p = 0.03)], thus demonstrating 
preserved or improved hippocampal-dependent learning and memory SynCav1 Tg mice after TBI (Figure 
4B); no significant difference between groups was observed in the cued re-exposure on day 3 (Figure 4C).  
After completion of the behavioral testing, we performed histological analysis using Cresyl violet stain to 
measure brain lesion volume from rostral to caudal as described in the Methods section.  Figure 5 
represents histological brain (n = 4 mice/group) sections showing damage to the motor cortex at bregma 
-0.50 mm (Figure 5A) and damage to the parietal cortex and underlying dorsal hippocampus at bregma 
-2.70 (Figure 5B). Postmortem analysis revealed that CCI significantly increase brain lesion volume in TG 
negative mice (6.9 ± 1.0 mm3; F(1,12) = 46.68, p < 0.0001; Figure 5C) compared to sham TG negative 
mice (craniotomy only; 0.005 ± 0.003 mm3).  In contrast, CCI-induced brain lesion volume was 
significantly reduced in SynCav1 TG positive mice (1.7 ± 0.7 mm3; F(1,12) = 17.64, p = 0.001, n=4) 
compared to TG negative mice subjected to CCI. These findings may in part explain for the motor and 
hippocampal-dependent behavioral resilience exhibited by SynCav1 TG mice subjected to CCI show in 
Figures 3 and 4. 
 Discussion 
Although previous work shows that increasing Cav-1 and MLRs specifically in neurons is 
neuroprotective(16), enhances pro-growth signaling, promotes neuroplasticity(17), and improves learning 
and memory in aged mice(18), the functional significance of neuron-targeted Cav-1 in the setting of brain 
trauma is not kown. In this study, we demonstrate that a mouse genetically engineered to contain a 
neuron-targeted Cav-1 construct expresses more MLR-associated synaptic proteins (PSD-95) and 
receptors (NR2A, NR2B, TrkB), exhibits greater motor function recovery, and demonstrates preserved 
contextual learning and memory months following brain trauma. This study provides proof of concept 
results that neuron-targeted over-expression of Cav-1 is neuroprotective against brain injury and extends 
upon previous findings that Cav-1 plays a necessary role in neurobehavioral function. 
Brain trauma disrupts neuronal networks and deteriorates cognitive function(3). The primary impact 
consists of mechanical-focal damage, diffuse axonal injury, and subsequent neuronal cell loss. The 
secondary delayed injury increases neuroinflammation, production of pro-inflammatory and growth 
inhibitory cytokines such as IL-1β, TNFα, and IFNγ(12, 24), all of which lead to chronic micro- and 
astrogliosis, and production of myelin-associated growth inhibitors (MAIs) such as myelin-associated 
glycoproteins (MAG) and Nogo that contribute to the delayed secondary injury(11). Secondary injury 
occurs hours to days to months after the initial primary impact and results in neurochemical, metabolic 
and cellular changes. The hostile environment generated by the activated microglia triggers the 
recruitment and chronic activation of astrocytes (i.e., astrogiosis). Astrogliosis is characterized by cellular 
proliferation and hypertrophy as demarked by increased glial fibrillary acidic protein expression, an 
intermediate filament protein.  We have previously shown in our CCI model, cortical (motor and parietal) 
and hippocampal damage, neuronal and neuropil loss, disruption of MLR and MLR-associated 
neuroprotective signaling components such as NMDARs and TrkB, and a significant increase in growth 
inhibitory cytokines and chemokines(12).  In the present study, the severe motor cortical damaged was 
evident relatively early as indicated by measurable functional motor deficits as assessed in the inverted 
grid test (Figure 3). However, when subjected to CCI, the SynCav1 Tg mice demonstrated better motor 
function recovery over time, demonstrating greater resilience when compared to Tg neg. The dorsal 
hippocampus which lies directly under the parietal cortex, was also severely injured as demonstrated by 
decreased hippocampal-dependent contextual fear learning and memory (Figure 4) and hippocampal 
tissue loss (Figure 5).  Similar to the motor recovery, SynCav1 TG mice also demonstrated preserved 
hippocampal-dependent contextual fear learning and memory.  We have previously shown that SynCav1 
gene delivery significantly promotes dendritic growth and arborization in primary neurons even in the 
presence of growth inhibitory cytokines and MAI(17), neuroprotective results which could explain in part 
for the observed improvement in both motor and hippocampal-dependent memory function exhibited by 
SynCav1 Tg mice in the present study.  Although the current study used well-established behavioral 
tests to assess changes in motor and memory, more sensitive electrophysiological assays such as motor 
evoke potentials (MEPs) and/or excitatory post-synaptic potentials (EPSP) would yield a better 
understanding of which neuronal circuits are disrupted in the current brain trauma model as well as which 
neuronal circuits are preserved in the SynCav1 Tg mouse.  
Restoration of functional neuronal connectivity is in part dependent upon establishing a polarized 
plasma membrane and the localization of functional pro-growth signaling receptors to these polarized 
platforms, thus transducing extracellular growth-stimulating cues to the underlying dynamic 
cytoskeleton(15, 25). These pro-growth signaling pathways promote axonal transport, dendritic growth, 
and formation of synaptic contacts. However, after nerve injury, the subcellular localization of these 
signaling components become disorganized or are decreased(12-14). A critical component of neuronal 
cell membrane polarity are MLR(15, 26), cholesterol and lipid enriched microdomains within the plasma 
membrane that partition synaptic proteins involved in signaling and plasticity(27). Cav-1 along with MLR 
provide this polarized membrane-signaling platform that facilitates intrinsic neuronal growth and repair, 
maintenance and neuroplasticity(15, 25). The importance of MLR in proper neuronal growth signaling, 
synaptic maintenance and neuroplasticity is underscored by evidence that disruption of MLR leads to 
synaptic loss, reduced dendritic spines, receptor instability, and disrupted growth cone motility(26, 27).  
Evidence shows that exogenous application of the pro-growth neurotrophin brain-derived neurotrophic 
factor (BDNF) enhances cholesterol in neurons and raises levels of neuronal Cav-1(28); moreover 
BDNF-TrkB signaling is dependent upon TrkB recruitment into neuronal MLR(29). The present study 
shows that SynCav1 Tg mice have enhanced TrkB expression in MLR (Figure 2), a subcellular event 
which not only facilitates BDNF-TrkB signaling, but is also critical for other tyrosine kinase receptor 
signaling cascades(27) and could contribute to the neurobehavioral resilience exhibited by the SynCav1 
Tg mice following brain trauma.  
Individuals with brain injury have an increased risk of neurological complications, neuropathological 
and neuropsychiatric changes, deficits in attention, suffer from post-traumatic stress disorder (PTSD), and 
have a higher incidence of neurodegenerative diseases such as AD, PD, and ALS later in life(6, 30-33). 
Disabilities associated with nerve injury lead to a greater requirement for institutional and long-term care 
in addition to exacerbating the already existing domestic burden, which bares with it an emotional, 
psychological, and physical cost. Despite intense investigative efforts, there is a lack of defined 
therapeutic approaches for the treatment of nerve injury, predominantly because many targeted therapies 
are often ineffective in eliciting the desired response, likely due to decreased expression of key receptors 
(TrkB, GPCRs)(12) and blunted second messenger (cAMP) signaling cascades necessary to evoke 
functional neuroplasticity(13, 14, 34). These pro-growth signaling deficits limit the capacity for 
neuroregeneration and re-innervation of neuronal circuits to their appropriate targets. Therefore, there 
exists an urgent need for the development of more innovative methods to limit neurodegeneration and 
improve neurologic function post injury. The delayed nature of the secondary injury suggests a potential 
therapeutic window to prevent progressive neurodegeneration by re-evoking neuroplastic signaling 
mechanisms, enhancing neuroregenerative capacity, and improving motor and cognitive function after 
injury.  Therefore, genetic interventions like neuron-targeted Cav-1, which not only enhances 
pro-growth/survival signaling within neurons and improves learning and memory, may also be exploited 
as a potential therapy to not only reverse complications associated with brain trauma, but might also 
protected against spinal cord trauma.   
Certain approaches such as the use of biologics (stem cells, peptide and gene therapy, exogenous 
growth factors), pharmacological agents, and/or noninvasive interventions (exercise or transcranial 
magnetic stimulation (TMS)) may work synergistically to improve motor and cognitive function months to 
years post brain trauma(24, 35). For example, SynCav1, which enhances MLR formation, 
receptor-mediated cAMP production, and TrkB signaling in neurons, could be used in combination with 
selective pharmacologic agents that stimulate MLR-associated TrkB receptors(36), augment cAMP with 
phophodiesterase inhibitors(13, 34, 37), or increase serotonin and/or dopamine with selective reuptake 
inhibitors(38-40) to promote functional neuroplasticity and improve behavior. In addition, non-invasive 
interventions such as exercise therapy or TMS can augment production of pro-growth molecules such as 
BDNF(35) and activate TrkB signaling(41). Thus enhancing TrkB-localization to MLR with neuron-targeted 
Cav-1 may work in concert with these non-invasive interventions to evoke neuroplastic changes 
necessary to improve motor and neurobehavioral function in individuals afflicted with brain trauma and 
trauma-induced neurodegeneration.  
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FIGURES 
 Figure 1. SynCav1 TG positive mice were confirmed by polymerase chain reaction (PCR) and ethidium 
bromide DNA gel electrophoresis. SynCav1 appears at 470 base pairs (bp) as indicated by the white 
arrow on left side of DNA molecular ladder. Vinculin (upper band) was used as a loading control (860 bp).  
 Figure 2. SynCav1 Tg mice express more hippocampal MLR-localized NMDARs (NRs), TrkB, and Cav-1.  
Hippocampal (Hpc) homogenates from Tg neg and SynCav1 Tg mice were immunoblotted for Cav-1, 
PSD95, NMDAR2A (NR2A), NR2B, and TrkB (A). β3-tubulin and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) were used as loading controls. Quantitation of protein expression are shown in 
B. Hpc tissue were subjected to sucrose density fractionation followed by immunoblot analysis for Cav-1, 
PSD95, NR2A, NR2B, and TrkB (C). Quantitation of protein expression are shown in D. Tg neg, open 
box; SynCav1 Tg, black box. All fractions were generated from equal protein loading of 0.5 mg/ml. Data (n 
= 3-4 mice/group) represent arbitrary units (A.U.) mean SEM. Significance was assumed when *p < 0.05. 
 
Figure 3. SynCav1 TG Mice Exhibit Improved Motor Function Recovery after Brain Trauma. TBI resulted 
in a significant decrease in holding impulse in both Tg neg (black bars) and SynCav1 mice (open bars) on 
day 7.  When comparing the recovery between day 7 and day 49 with a paired t-test, all groups except 
for TBI/sham significantly improved their motor recovery as indicated by a significant increase in the 
holding impulse [body weight (g) * hanging time (sec.)/102]. Data (n = 11-22 mice/group) are presented as 
mean ± SEM. Significance was assumed when **p < 0.05. 
 Figure 4. SynCav1 TG mice show preserved contextual fear learning and memory months after brain 
trauma. (A) Both groups showed similar acquisition in response to the conditioned stimulus 2 months post 
CCI; this was reflected in a significant effect of time during the repetitive exposure of the tone/shock 
pairings, with no significance for gene or time x gene interaction. (B) On day 2, contextual re-exposure 
demonstrated a significant decrease in percent freezing in Tg neg/TBI mice (black bars) (*p = 0.03) 
versus Tg neg/Sham. SynCav1/TBI mice (open bars) demonstrated significant preserved or improved 
hippocampal-dependent learning and memory (*p = 0.03) when compared to Tg neg/TBI mice. (C) No 
significant difference between groups was observed in the cued re-exposure on day 3. Data (n = 21-22 
mice/group) are presented as mean ± SEM. Significance was assumed when p < 0.05.  
 
Figure 5. SynCav1 TG mice exhibit smaller cortical lesion size 2 months after brain trauma. Bright field 
microscopy of Cresyl violet stained brain sections showing damage to the motor cortex at bregma -0.50 
mm (A) and damage to the parietal cortex and underlying dorsal hippocampus at bregma -2.70 (B). 
Quantitation of total lesion volume (mm3) is shown in C. Data (n = 4 mice/group) are presented as mean ± 
SEM. Significance was assumed when p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
